Antimicrobial use for treatment of healthcare-associated infections and bacterial resistance in a reference neonatal unit.


Journal

Jornal de pediatria
ISSN: 1678-4782
Titre abrégé: J Pediatr (Rio J)
Pays: Brazil
ID NLM: 2985188R

Informations de publication

Date de publication:
Historique:
received: 28 01 2020
revised: 03 06 2020
accepted: 03 06 2020
pubmed: 28 6 2020
medline: 25 5 2021
entrez: 28 6 2020
Statut: ppublish

Résumé

The use of broad-spectrum antimicrobials, such as third and fourth-generation, are responsible for emergence of multidrug-resistant microorganisms in neonatal units. Furthermore, antimicrobial daily doses are not standardized in neonatology. This study aimed to investigate the association between the use of antimicrobial broad spectrum to bacterial sensitivity profile in a referral unit of neonatal progressive care. This is a cohort study conducted in a referral neonatal progressive care unit from January 2008 to December 2016. The data of all hospitalized neonates was collected daily. The infection criteria used were the standardized national criteria, based on definitions of Center for Diseases Control and Prevention. In this study, the use of antimicrobials was evaluated as antimicrobial-day (ATM-day) and the ratio of multidrug-resistant microorganisms per 1000 ATM-day of broad spectrum was also calculated. The study was approved by the Institutional Review Board of the Universidade Federal de Minas Gerais (ETIC 312/08 e CAAE 58973616.2.0000.5149). From 2008 to 2016, 2751 neonates were hospitalized, corresponding to 60,656 patient-days. The ratio of multidrug-resistant microorganisms per 1000 ATM-day of broad spectrum was 1,3 in the first period and 4,3 in the second period (p=0,005). It was observed that use of broad-spectrum antimicrobials, especially those with coverage for Gram-negative bacteria, was associated with an increase of multidrug-resistant bacteria.

Identifiants

pubmed: 32592659
pii: S0021-7557(20)30184-4
doi: 10.1016/j.jped.2020.06.001
pmc: PMC9432030
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Anti-Infective Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

329-334

Informations de copyright

Copyright © 2020 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.

Références

J Hosp Infect. 2003 Mar;53(3):198-206
pubmed: 12623321
Semin Perinatol. 2012 Dec;36(6):431-6
pubmed: 23177802
J Hosp Infect. 2011 Oct;79(2):161-5
pubmed: 21820760
J Trop Pediatr. 2015 Feb;61(1):1-13
pubmed: 25604489
Infect Control Hosp Epidemiol. 2004 Sep;25(9):781-3
pubmed: 15484805
Pediatr Infect Dis J. 2011 May;30(5):365-70
pubmed: 21099446
Braz J Infect Dis. 2018 Jul - Aug;22(4):328-337
pubmed: 30125532
Early Hum Dev. 2015 Nov;91(11):613-8
pubmed: 26386612
Pediatr Infect Dis J. 2011 Apr;30(4):273-8
pubmed: 21085051
Pediatr Neonatol. 2018 Feb;59(1):35-41
pubmed: 28642139
Clin Perinatol. 2010 Sep;37(3):547-63
pubmed: 20813270
Pediatr Infect Dis J. 2009 Dec;28(12):1047-51
pubmed: 19858773
Indian J Pediatr. 2020 Feb;87(2):117-121
pubmed: 31828600
Lancet. 2000 Mar 18;355(9208):973-8
pubmed: 10768436
Pediatr Infect Dis J. 2002 Nov;21(11):1029-33
pubmed: 12442024
Neonatology. 2011;100(2):180-5
pubmed: 21455008
Semin Fetal Neonatal Med. 2017 Oct;22(5):278-283
pubmed: 28735809
J Perinatol. 2008 Oct;28(10):685-90
pubmed: 18580881
J Pediatr (Rio J). 2016 Sep-Oct;92(5):472-8
pubmed: 27112033
Infect Dis Clin North Am. 2014 Jun;28(2):247-61
pubmed: 24857391
Acta Paediatr. 2003 Oct;92(10):1205-7
pubmed: 14632339
Pediatr Infect Dis J. 2008 Apr;27(4):314-8
pubmed: 18316990
Am J Infect Control. 2001 Jun;29(3):133-8
pubmed: 11391273
Pediatr Infect Dis J. 2015 Apr;34(4):371-5
pubmed: 25760564
Pediatrics. 2000 Dec;106(6):1387-90
pubmed: 11099593
Clin Perinatol. 2015 Mar;42(1):1-16, vii
pubmed: 25677993
Pediatrics. 2014 Feb;133(2):e322-9
pubmed: 24420803
Infection. 2007 Oct;35(5):339-45
pubmed: 17721736
Indian Pediatr. 2010 Sep;47(9):785-8
pubmed: 21048261
Ital J Pediatr. 2015 Apr 01;41:27
pubmed: 25887621

Auteurs

Ana Carolina Bueno E Silva (ACBE)

Universidade Federal de Minas Gerais (UFMG), Faculdade de Medicina, Centro de Pós graduação, Belo Horizonte, MG, Brazil; Pontifícia Universidade Católica de Minas Gerais, Belo Horizonte, MG, Brazil. Electronic address: acbuenos@yahoo.com.br.

Leni Márcia Anchieta (LM)

Universidade Federal de Minas Gerais (UFMG), Faculdade de Medicina, Departamento de Pediatria, Belo Horizonte, MG, Brazil.

Viviane Rosado (V)

Universidade Federal de Minas Gerais (UFMG), Hospital das Clínicas, Serviço de Controle de Infecção Hospitalar, Belo Horizonte, MG, Brazil.

Janita Ferreira (J)

Universidade Federal de Minas Gerais (UFMG), Hospital das Clínicas, Serviço de Controle de Infecção Hospitalar, Belo Horizonte, MG, Brazil.

Wanessa Trindade Clemente (WT)

Universidade Federal de Minas Gerais (UFMG), Faculdade de Medicina, Departamento Propedêutico, Belo Horizonte, MG, Brazil.

Julia Sampaio Coelho (JS)

Universidade Federal de Minas Gerais (UFMG), Faculdade de Medicina, Departamento de Pediatria, Belo Horizonte, MG, Brazil.

Paulo Henrique Orlandi Mourão (PHO)

Universidade Federal de Minas Gerais (UFMG), Hospital das Clínicas, Serviço de Controle de Infecção Hospitalar, Belo Horizonte, MG, Brazil.

Roberta Maia de Castro Romanelli (RMC)

Universidade Federal de Minas Gerais (UFMG), Faculdade de Medicina, Departamento de Pediatria, Belo Horizonte, MG, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH